Persons Reported to be living with HIV infection and with AIDS reported
Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 12,367 14,910 314 185 12,681 15,095 27,227 499 27,776
2001

13,119

15,542

 318 160 13,437 15,702 28,661 478 29,139
2002 15,391 15,343 419 142 15,810 15,485 30,734 561 31,295
                   

 

HIV Infection Cases  from areas with confidential HIV infection reporting
Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 1,455 13,836 379 14,215
2001 1,571 14,770 403 15,173
2002 1,208 15,391 419 15,810
         

 

Adult/Adolescent HIV infection and AIDS cases reported in the United States
Year Males Females
  HIV AIDS HIV AIDS
2000 901 1,297 522 616
2001 959 1,159 583 588
         

 

New Pediatric AIDS cases reported

Year
2000 16
2001 9

 

AIDS cases and annual rates per 100,000 population by Metropolitan area reported through June 2001

 

 1999

2000

2001

Cumulative Totals
City No No. No. Adults / Adolescents Children under 13 Years old Total
Bergen - Passaic 248 210 187 5,608 83 5,691
Jersey City 249 220 256 6,735 120 6,855
Middlesex 113 132 147 3,286 71 3,357
Monmouth - Ocean 106 129 126 2,942 62 3,004
Newark 914 773 711 17,469 327 17,796

 

Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 45,237
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 44,473
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 764

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002
  NJ USA
Men 31,601 680,909
Women 12,252 146,298
Total 43,853 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 1,436
New Adult/Adolescent AIDS Cases, Reported in 2001 1,747
New AIDS Cases in Children <13, Reported through December 2001 9

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported in 2001
  NJ USA
Men 1,159 31,901
Women 588 11,082
Total 1,747 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 15,485
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 15,343
Estimated Number of Children Living with AIDS at the End of 2002 142
HIV Infection Cases Reported in 2002 1,208

 

Total Deaths Reported through 2000, due to AIDS = 26,705
HIV Reporting Requirements ?   Yes, Name Based.
 
HIV Testing Options?  Anonymous and Confidential testing
Definitions: Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing? Providers required to offer HIV test. Providers are required by law to offer HIV testing to pregnant women.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration? NO
Definitions: 1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 
Sterile Syringe Exchange Programs?  Yes
Notes: U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  Yes, Must stress abstinence.
Minors' Right to Consent to HIV/STD Services?  Yes. Physician may notify parents.
 
 

 

Total Ryan White Funding, FY2000   $77,177,642 FY2002  $86,828,754

 

CDC HIV Prevention Funding for States
 FY2001  $13,829,529

 FY2003   $13,928,051

 

Total Federal and State Funding for ADAP, FY2001  $29,467,198

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  NJ
#		 US
#
   3,322 80,035

 
ADAP Clients Served by Sex, June 2002  
  NJ
#		 NJ
%		 US
#		 US
%
  Male 2,212 67 62,034 78
  Female 1,110 33 16,702 21
  Total 3,322 100 79,531 100

 
ADAP Clients Served by Race/Ethnicity, June 2002  
  NJ
#		 NJ
%		 US
#		 US
%
  White 734 22 29,426 37
  Black 1,721 52 26,245 33
  Hispanic 791 24 19,883 25
  Asian/Pacific Islander 3 0 795 1
  American Indian/Alaskan Native 13 0 795 1
  Other 53 2 795 1
  Total 3,322 100 79,531 100

 
ADAP Clients Served by Age, June 2002  
  NJ
#		 NJ
%		 US
#		 US
%
  <13 years old 23 1 795 1
  13-19 years old 23 1 0 1 0 1
  20-44 years old 2,026 61 50,105 63
  >44 years old 1,249 38 27,836 35
  Total 3,322 100 79,531 100

 
ADAP Clients Served by Income, June 2002  
  NJ
#		 NJ
%		 US
#		 US
%
  <100% FPL 1,668 50 38,175 48
  101-200% FPL 681 21 26,245 33
  201-300% FPL 482 14 8,748 11
  301-400% FPL 286 9 3,181 4
  >400% FPL 209 6 1,591 2
  Total 3,322 100 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
  NJ
#		 NJ
%		 US
#		 US
%
  Medicaid 0 0 0 10
  Medicare 213 6 0 6
  Private 664 20 0 13

 
National ADAP Budget, Total Federal and State Sources, FY 2002  
  NJ
$		 US
$
   41,310,395 878,610,754

 
National ADAP Budget by Source, FY 2002  
  NJ
$		 NJ
%		 US
$		 US
%
  ADAP Earmark 31,624,395 77 619,830,000 71
  Title II Base 0 0 28,886,192 3
  State 0 0 160,385,979 18
  Title I 0 0 19,736,619 2
  Other Federal 9,686,000 23 30,941,439 4
  ADAP Supplemental Grants 0 0 19,170,000 2
  Total 41,310,395 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  NJ
$		 US
$
   3,769,854 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  NJ
$		 NJ
%		 US
$		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 1,322,164 35 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 718,473 19 7,940,575 12
  Protease Inhibitors 953,052 25 16,433,502 25
  Opportunistic Infections/Other 776,165 21 9,015,329 14
  Total 3,769,854 100 64,875,793 100

 
Total ADAP Prescriptions Filled, June 2002  
  NJ
#		 US
#
   14,110 257,279

 
ADAP Prescriptions Filled by Drug Class, June 2002  
  NJ
#		 NJ
%		 US
#		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 4,335 31 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors 1,744 12 23,933 10
  Protease Inhibitors 2,013 14 33,813 15
  Opportunistic Infections/Other 6,018 43 87,746 38
  Total 14,110 100 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  NJ
$		 US
$
   NA 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  NJ
#		 US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 3 NA
  OI Prophylaxis Covered 14 NA
  Other Medications Covered NA  NA
  Total 32 NA

 
ADAP Emergency Cost Containment Measures, February 2003  
  NJ
 		 US
 
  Has ADA